BioSpace News Archive

Investors Skeptical as Gilead’s Presents Mixed Data for Its Phase II NASH Trial

November 15, 2016
·
6 min read
Drug Development

Bayer Announces Phase III Study To Evaluate New Pediatric Formulation Of Nifurtimox For Potential Treatment Of Chagas Disease

November 15, 2016
·
6 min read
Drug Development

Janssen R&D Next-Generation Biologic Guselkumab Shows Promise In The Treatment Of Psoriatic Arthritis In Phase 2 Trial

November 15, 2016
·
8 min read
Drug Development

First Patient Enrolled In Mallinckrodt Phase 4 Trial Of H.P. Acthar Gel For Lupus

November 15, 2016
·
8 min read
Biotech Beach

Zymo Research Launches Three Plasmid Purification Kits Based On Innovative Zymopure Technology

November 15, 2016
·
2 min read
Genetown

Berg Presents Data Uncovering A Novel Contributor To Parkinson’s Disease At Society For Neuroscience 2016 Meeting

November 15, 2016
·
4 min read
Senhwa Biosciences Files New Patent Applications For Use Of CX-5461 In Combination With PARP Inhibitors, PI3K And Immunotherapeutic Agents

November 15, 2016
·
2 min read
Drug Development

Viking Therapeutics Presents New Clinical Data On VK2809 In Subjects With Elevated Cholesterol At AHA Scientific Sessions 2016

November 15, 2016
·
7 min read
Pharm Country

Johnson & Johnson Innovation And Janssen Award U.S. $1.5 Million In Grants For World Without Disease Quickfire Challenge

November 15, 2016
·
6 min read
Business

Blueprint Medicines Announces Appointment Of Marion Dorsch, Ph.D. As Chief Scientific Officer And The Transition of Christoph Lengauer, Ph.D., MBA, To A Newly Created Executive Vice President Role

November 15, 2016
·
7 min read